Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 6/20 | 0.42 |
| ▸ | RAB9A | P51151 | 6/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.42 |
| ▸ | MAPT | P10636 | 4/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.42 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.42 |
| ▸ | RELA | Q04206 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.41 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.41 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.41 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.41 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.41 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2679072 | 0.83 | NPC1 (0.47) | NPC1RAB9ASMN1; SMN2KMT2AMAPT | |
| SCHEMBL16210072 | 0.83 | MEN1 (0.59) | NPC1RAB9ASMN1; SMN2KMT2AMAPT | |
| SCHEMBL16320822 | 0.80 | CYP2A6 (0.62) | NPC1RAB9ASMN1; SMN2KMT2AMAPT | |
| SCHEMBL8891737 | 0.79 | KDM4E (0.41) | NPC1RAB9ASMN1; SMN2KMT2AMAPT | |
| SCHEMBL12441003 | 0.79 | MEN1 (0.56) | NPC1RAB9ASMN1; SMN2KMT2AMAPT | |
| SCHEMBL1104786 | 0.77 | RAB9A (0.50) | NPC1RAB9ASMN1; SMN2KMT2AMAPT | |
| SCHEMBL190954 | 0.77 | AURKA (0.63) | NPC1RAB9ASMN1; SMN2KMT2AMAPT | |
| SCHEMBL29620532 | 0.77 | AURKA (0.63) | NPC1RAB9ASMN1; SMN2KMT2AMAPT | |
| SCHEMBL18212399 | 0.77 | KMT2A (0.53) | NPC1RAB9ASMN1; SMN2KMT2AMAPT | |
| SCHEMBL8842447 | 0.76 | KMT2A (0.72) | NPC1RAB9ASMN1; SMN2KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106432096-B | Compound derived from cis-stilbene/fluorene spirochete and photoelectric device thereof | 彩丰精技股份有限公司 | 2021-03-30 | — | — | CN | disclosed |
| CN-110437153-A | hepatitis B core protein allosteric modulators | UNIV INDIANA RES & TECH CORP | 2019-11-12 | — | — | CN | disclosed |
| CN-109311839-A | Methylamine derivative is used for treating cancer as lysyl oxidase inhibitor | 癌症研究协会皇家癌症医院 | 2019-02-05 | — | — | CN | disclosed |
| US-10193083-B2 | Spirally configured cis-stilbene/fluorene hybrid compounds and organic light emitting device comprising the same | NICHEM FINE TECHNOLOGY CO., LTD. (TW) | 2019-01-29 | — | — | US | disclosed |
| CN-104736537-B | Organic luminescent compounds and the organic electroluminescent device for using it | 株式会社斗山 | 2019-01-22 | — | — | CN | disclosed |
| CN-108884090-A | Heterocyclic compound and the organic illuminating element for using it | 喜星素材株式会社 | 2018-11-23 | — | — | CN | disclosed |
| CN-108017644-A | A kind of nitogen-contained heterocycle derivant and its application | 北京鼎材科技有限公司 | 2018-05-11 | — | — | CN | disclosed |
| CN-107602468-A | One kind contains anthracene compound and its synthetic method and organic luminescent device | 长春海谱润斯科技有限公司 | 2018-01-19 | — | — | CN | disclosed |
| US-20170256719-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRICAL ELEMENT USING COMPOUND, AND ELECTRONIC DEVICE COMPRISING SAME | DUK SAN NEOLUX CO., LTD (KR) | 2017-09-07 | — | — | US | disclosed |
| US-20170256719-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRICAL ELEMENT USING COMPOUND, AND ELECTRONIC DEVICE COMPRISING SAME | DUK SAN NEOLUX CO., LTD (KR) | 2017-09-07 | — | — | US | disclosed |
| US-9324954-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2016-04-26 | — | — | US | disclosed |
| CN-105392778-A | Polycyclic compound and organic light emitting device using the same | HEESUNG MAT LTD | 2016-03-09 | — | — | CN | disclosed |
| CN-105358533-A | Heterocyclic compound and organic light-emitting device using the same | HEESUNG MAT LTD | 2016-02-24 | — | — | CN | disclosed |
| CN-104736537-A | Organic light-emitting compound and organic electroluminescent device using same | DOOSAN CORP | 2015-06-24 | — | — | CN | disclosed |
| CN-104086488-A | Synthetic method of 2,4,6-tri-substituted pyrimidine compounds | UNIV HENAN NORMAL | 2014-10-08 | — | — | CN | disclosed |
| US-20130240796-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | Merck Patent GmnH (DE) | 2013-09-19 | — | — | US | disclosed |
| CN-103228647-A | Materials for organic electroluminescent devices | MERCK PATENT GMBH | 2013-07-31 | — | — | CN | disclosed |
| CN-102656164-A | Pyrimidine compounds as tuberculosis inhibitors | VERTEX PHARMA | 2012-09-05 | — | — | CN | disclosed |
| WO-2012069121-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2012-05-31 | — | — | WO | disclosed |
| US-5626791-A | FERROELECTRIC LIQUID CRYSTALS | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170256719-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRICAL ELEMENT USING COMPOUND, AND ELECTRONIC DEVICE COMPRISING SAME | ORAI2, VDAC2, PIEZO1 | NPC1 2710/4885RAB9A 3355/4885SMN1; SMN2 741/4885 |
| US-10193083-B2 | Spirally configured cis-stilbene/fluorene hybrid compounds and organic light emitting device comprising the same | SLCO2B1, SLCO4C1, SLCO1B1 | NPC1 284/4885RAB9A 767/4885SMN1; SMN2 2958/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.